CLINICAL STUDY IN THE MANAGEMENT OF STROKE (PAKSHAGHATA) WITH MAHARASNADI KASHAYA AND SHUNTI CHURNA

AN OPEN LABEL SINGLE ARM PROSPECTIVE CLINICAL STUDY IN THE MANAGEMENT OF PAKSHAGHATA(CEREBRO VASCULAR ACCIDENT DUE TO INFARCT) WITH MAHARASNADI KASHAYA AND SHUNTI CHURNA

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/04/018440

Enrollment

Registered

2019-04-08

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I639- Cerebral infarction, unspecified

Interventions

Intervention1: Maharasnadi Kashay with ShuntiChurna: Maharasnadi Kashay 50ml with ShuntiChurna1 Â½ gm sanupana twice daily after food for 7 days Control Intervention1: not applicable: not applicable

Eligibility

Inclusion criteria

Inclusion criteria: Pakshaghata associated with disease/s likecontrolled Diabetes Mellitus, Hypertension, Hyperlipidemia(Any of these or all of these). Those who are ready to sign the informed consent form.

Exclusion criteria

Exclusion criteria: K/C/O HbSAg, HIV, Carcinoma,renal disorders, COPD. H/O or E/O Intra cranial infection â?? encephalitis, meningitis,cerebral tumor, cerebralabscess, and congenital defects- diffused sclerosis, cerebral agenesis.

Design outcomes

Primary

Measure	Time frame
Cheshtanivritti Vaaksthambha Ruja Timepoint: on 7th day	—

Secondary

Measure	Time frame
National institute of health (NIH) stroke scaleTimepoint: will be assessed on 7th day	—

Countries

India

Contacts

Public ContactDRM ROHAN M MOHANDAS

SDM COLLEGE of Ayurveda and hospital Thanniruhalla Hassan

totadmv225@gmail.com9886924949

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026